Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

Haematologica

Volumn 95, Issue 6, 2010, Pages 860-863

  Clark, William B ^a   Strickland, Stephen A ^a   Barrett, A John ^b   Savani, Bipin N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; AZACITIDINE; CARBOPLATIN; CYTARABINE; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; IFOSFAMIDE; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGE DISTRIBUTION; ALLOGENEIC STEM CELL TRANSPLANTATION; BREAST METASTASIS; CANCER SURVIVAL; DONOR LYMPHOCYTE INFUSION; DRUG MEGADOSE; EDITORIAL; EXTRAMEDULLARY RELAPSE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; INGUINAL LYMPH NODE; LEUKEMIA RELAPSE; LYMPHATIC LEUKEMIA; MYELODYSPLASTIC SYNDROME; RECURRENT CANCER; RISK FACTOR; SURVIVAL TIME; T CELL DEPLETION; TISSUE DISTRIBUTION; TREATMENT RESPONSE;

ANIMALS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; POSTOPERATIVE COMPLICATIONS; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 77953268080     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.025890     Document Type: Editorial

References (22)

1. Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, et al. Factors predicting long-term survival after T cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica. 2010;95(6):989-95.
2. Békássy AN, Hermans J, Gorin NC, Gratwohl A. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1996;17(5):801-8.
3. Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma. 2006;47(9):1754-67.
4. Frassoni F, Barrett AJ, Grañena A, Ernst P, Garthon G, Kolb HJ, et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol. 1988;70(3):317-20.
5. Berthou C, Léglise MC, Herry A, Balcon D, Hardy E, Lessard M, Abgrall JF. Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia. Leukemia. 1998;12(11):1676-81.
6. Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer. 1999;85(3):608-15.
7. Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003;32(8):835-42.
8. Shimoni A, Rand A, Shem-Tov N, et al. Isolated Extra-Medullary Relapse of Acute Leukemia After Allogeneic Stem-Cell Transplantation (SCT); Different Kinetics and Better Prognosis than Systemic Relapse. Biol Blood Marrow Transplant. 2009;15 (2 supplement 1):59.
9. Harris AC, Mageneau J, Braun T, et al. Extramedullary Relapse In Acute Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors And Outcomes. Biol Blood Marrow Transplant 2010;16 (2 supplement 1):S177-S178.
10. Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P, et al. Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer. 2009;115(9):1899-905.
11. Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant. 2000;26(9):1011-5.
12. Yoshihara S, Tamaki H, Ikegame K, et al. Early prediction of extramedullary relapse of leukemia following allogeneic stem cell transplantation using the WT1 transcript assay. Biol Blood Marrow Transplant 2006;12 (2 supplement 1):86.
13. Kikushige Y, Takase K, Sata K, Aoki K, Numata A, Miyamoto T, et al. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations. Intern Med. 2007;46(13):1011-4.
14. Szomor A, Passweg JR, Tichelli A, Hoffmann T, Speck B, Gratwohl A. Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation. Ann Hematol. 1997;75(5-6):239-41.
15. Kobayashi M, Imamura M, Soga R, Tsuda Y, Maeda S, Iwasaki H, et al. Establishment of a novel granulocytic sarcoma cell line which can adhere to dermal fibroblasts from a patient with granulocytic sarcoma in dermal tissues and myelofibrosis. Br J Haematol. 1992;82(1):26-31.
16. Kuwabara H, Nagai M, Yamaoka G, Ohnishi H, Kawakami K. Specific skin manifestations in CD56 positive acute myeloid leukemia. J Cutan Pathol. 1999;26(1):1-5.
17. Sackstein R. A Revision of Billingham's Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2006;12(1 Suppl 1):2-8.
18. Savani BN, Mielke S, Reddy N, Goodman S, Jagasia M, Rezvani K. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant. 2009;44(12):769-77.
19. Choi ER, Ko YH, Kim SJ, Jang JH, Kim K, Kang WK. Gastric Recurrence of Extramedullary Granulocytic Sarcoma After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia. J Clin Oncol. 2010;28(4):e54-e55.
20. Au WY, Ma SK, Kwong YL, Lie AK, Shek WH, Chow WC, Liang R. Acute myeloid leukemia relapsing as gynecomastia. Leuk Lymphoma. 1999;36(1-2):191-4.
21. Ando T, Mitani N, Matsunaga K, Nakazora T, Gondo T, Yujiri T, Tanizawa Y. Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation. Tohoku J Exp Med. 2010;220(2):121-6.
22. Owonikoko T, Agha M, Balassanian R, Smith R, Raptis A. Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant. Nat Clin Pract Oncol. 2007;4(8):491-5.